Patents by Inventor Koji Suematsu

Koji Suematsu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF JUDGING RISK FOR ONSET OF DRUG-INDUCED GRANULOCYTOPENIA
    Publication number: 20140186826
    Abstract: Means for determining the presence of the risk of drug-induced granulocytopenia in a human is provided. A method for assessing the risk of drug-induced granulocytopenia, including detecting a polymorphism of the human insulin receptor substrate-2 gene of a subject, and determining the presence of the risk of drug-induced granulocytopenia of the subject by use of the genetic polymorphism as an index.
    Type: Application
    Filed: June 13, 2013
    Publication date: July 3, 2014
    Applicant: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Koji SUEMATSU, Koichi Hasegawa
  • Method of judging risk for onset of drug-induced granulocytopenia
    Patent number: 8492087
    Abstract: Means for determining the presence of the risk of drug-induced granulocytopenia in a human is provided. A method for assessing the risk of drug-induced granulocytopenia, including detecting a polymorphism of the human insulin receptor substrate-2 gene of a subject, and determining the presence of the risk of drug-induced granulocytopenia of the subject by use of the genetic polymorphism as an index.
    Type: Grant
    Filed: July 9, 2010
    Date of Patent: July 23, 2013
    Assignee: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Koji Suematsu, Koichi Hasegawa
  • METHOD OF JUDGING RISK FOR ONSET OF DRUG-INDUCED GRANULOCYTOPENIA
    Publication number: 20100273175
    Abstract: Means for determining the presence of the risk of drug-induced granulocytopenia in a human is provided. A method for assessing the risk of drug-induced granulocytopenia, including detecting a polymorphism of the human insulin receptor substrate-2 gene of a subject, and determining the presence of the risk of drug-induced granulocytopenia of the subject by use of the genetic polymorphism as an index.
    Type: Application
    Filed: July 9, 2010
    Publication date: October 28, 2010
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: KOJI SUEMATSU, KOICHI HASEGAWA
  • METHOD OF JUDGING RISK FOR ONSET OF DRUG-INDUCED GRANULOCYTOPENIA
    Publication number: 20100273176
    Abstract: Means for determining the presence of the risk of drug-induced granulocytopenia in a human is provided. A method for assessing the risk of drug-induced granulocytopenia, including detecting a polymorphism of the human insulin receptor substrate-2 gene of a subject, and determining the presence of the risk of drug-induced granulocytopenia of the subject by use of the genetic polymorphism as an index.
    Type: Application
    Filed: July 9, 2010
    Publication date: October 28, 2010
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Koji SUEMATSU, Koichi Hasegawa
  • Method of judging risk for onset of drug-induced granulocytopenia
    Patent number: 7790372
    Abstract: Means for determining the presence of the risk of drug-induced granulocytopenia in a human is provided. A method for assessing the risk of drug-induced granulocytopenia, including detecting a polymorphism of the human insulin receptor substrate-2 gene of a subject, and determining the presence of the risk of drug-induced granulocytopenia of the subject by use of the genetic polymorphism as an index.
    Type: Grant
    Filed: July 28, 2004
    Date of Patent: September 7, 2010
    Assignee: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Koji Suematsu, Koichi Hasegawa
  • Method of Judging Risk for Onset of Drug-Induced Granulocytopenia
    Publication number: 20070264631
    Abstract: Means for determining the presence of the risk of drug-induced granulocytopenia in a human is provided. A method for assessing the risk of drug-induced granulocytopenia, including detecting a polymorphism of the human insulin receptor substrate-2 gene of a subject, and determining the presence of the risk of drug-induced granulocytopenia of the subject by use of the genetic polymorphism as an index.
    Type: Application
    Filed: July 28, 2004
    Publication date: November 15, 2007
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Koji Suematsu, Kouichi Hasegawa
  • Heat sensitive recording material and recording method using the same
    Patent number: 5876898
    Abstract: A heat sensitive recording material is provided which can be simply prevented from falsification and is excellent in contrast between fixed portion and image portion, and a recording method using it is further provided. Moreover, there is provided a heat sensitive recording material capable of carrying out multicolor recording which is excellent in contrast of the image portions, density of the image portions, and image storage stability.
    Type: Grant
    Filed: July 16, 1996
    Date of Patent: March 2, 1999
    Assignee: Mitsubishi Paper Mills Limited
    Inventors: Haruhiko Ikeda, Shigetoshi Hiraishi, Koji Suematsu